Articles

Moffitt Cancer Center study findings show risk is greater among unmarried men and men who smoke. Read More ›

Trial results were presented at 2013 ESMO World Congress on Gastrointestinal Cancer. Read More ›

Study reveals that surgeries to remove tumors in soft tissue of limbs do not always involve an oncology specialist. Read More ›

Study by Johns Hopkins researchers may affect future treatment plans for African American men diagnosed with very low-risk prostate cancer. Read More ›

Study shows medical insurance coverage may influence the growing number of papillary thyroid cancer diagnoses. Read More ›

New study shows that more than 6% of patients diagnosed with melanoma experience a recurrence a decade or more following initial treatments. Read More ›

Study shows higher mortality rates among survivors of heart failure diagnosed with cancer. Read More ›

This article discusses ongoing clinical investigations of the agent in a wide range of therapeutic areas. Read More ›

Bendamustine is currently approved for the treatment of chronic lymphocytic leukemia (CLL), and many ongoing studies are investigating its efficacy in drug combinations. Read More ›

Bendamustine has demonstrated activity as monotherapy and in combination for patients with lymphoid and hematologic as well as solid tumors. Read More ›